How is it Different from Individual Expanded Access and Clinical Trials?
While individual expanded access focuses on single patients, intermediate size patient population expanded access involves groups of patients. Unlike clinical trials, which have strict eligibility criteria and are designed to gather extensive data on drug efficacy and safety, expanded access primarily aims to provide treatment options for patients who lack them. The data collected in expanded access programs are generally less comprehensive than those gathered in clinical trials.
